• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Transgene Biotek Ltd — Board Meeting, 13-02-2026: Board Meeting

    13-02-2026 | 12:06 pm

    Transgene Biotek's board approved Q3 FY26 standalone & consolidated results. For the quarter ended Dec 31, 2025, revenue was ₹0.05 Cr, and the company reported a net loss of ₹0.37 Cr.

    No comments yet. Be the first to comment!

    All announcements from Transgene Biotek Ltd